Literature DB >> 2677251

Human and simian glial cells infected by human T-lymphotropic virus type I in culture.

K Watabe1, T Saida, S U Kim.   

Abstract

Although human T-lymphotropic virus type I (HTLV-I) has been implicated in the etiology of tropical spastic paraparesis (TSP) and HTLV-I associated myelopathy (HAM), the direct infectivity of the virus against constituent cells in the central nervous system remains undetermined. To investigate the neurotropism of HTLV-I, we exposed cultured human and simian glial cells to HTLV-I. Primary mixed glial cell cultures of astrocytes and oligodendrocytes were obtained from adult human and cynomolgus monkey (Macaca fascicularis) brains by an enzyme digestion-Percoll gradient method. After two weeks in vitro, the cells were co-cultured with irradiated MT-2 cells, an HTLV-I-producing T-cell line. Cultures were double stained with antibodies against cell-type specific markers and anti-HTLV-I p19 (gag) monoclonal antibody. The HTLV-I antigen was demonstrated in small numbers of glial fibrillary acidic protein-positive cells (astrocytes) and galactocerebroside-positive cells (oligodendrocytes) in both the human and simian cultures. Electron microscopy demonstrated the presence of type C virus-like particles in the cytoplasm of astrocytes. These results indicate that HTLV-I is capable of infecting human and simian glial cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677251     DOI: 10.1097/00005072-198911000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  19 in total

1.  Effect of human T lymphotropic retrovirus-I exposure on cultured human glioma cell lines.

Authors:  B Macchi; B Caronti; M Pezzella; E Bonmassar; G Lauro
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.

Authors:  Saifur Rahman; Sharrón L Manuel; Zafar K Khan; Brian Wigdahl; Edward Acheampong; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

Review 3.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

4.  Provirus expansion and deregulation of apoptosis-related genes in the spinal cord of a rat model for human T-lymphocyte virus type I-associated myeloneuropathy.

Authors:  Utano Tomaru; Hitoshi Ikeda; Xiuyun Jiang; Osamu Ohya; Takashi Yoshiki
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

5.  Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo.

Authors:  G Feuer; J K Fraser; J A Zack; F Lee; R Feuer; I S Chen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes.

Authors:  M Tillmann; R Wessner; B Wigdahl
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Infectivity of human T-lymphotropic virus type I to human nervous tissue cells in vitro.

Authors:  T Akagi; Y Hoshida; T Yoshino; N Teramoto; E Kondo; K Hayashi; K Takahashi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.

Authors:  E Wu; D W Dickson; S Jacobson; C S Raine
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.

Authors:  Josefina D Piñon; P J Klasse; Sushma R Jassal; Sandy Welson; Jonathan Weber; David W Brighty; Quentin J Sattentau
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system.

Authors:  R E Sutton; D R Littman
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.